APA

Ashkenazi A., Pai R. C., Fong S., Leung S., Lawrence D. A., Marsters S. A., Blackie C., Chang L., McMurtrey A. E., Hebert A., DeForge L., Koumenis I. L., Lewis D., Harris L., Bussiere J., Koeppen H., Shahrokh Z. & Schwall R. H. (19990812). Safety and antitumor activity of recombinant soluble Apo2 ligand. : The Journal of clinical investigation.

Chicago

Ashkenazi A, Pai R C, Fong S, Leung S, Lawrence D A, Marsters S A, Blackie C, Chang L, McMurtrey A E, Hebert A, DeForge L, Koumenis I L, Lewis D, Harris L, Bussiere J, Koeppen H, Shahrokh Z and Schwall R H. 19990812. Safety and antitumor activity of recombinant soluble Apo2 ligand. : The Journal of clinical investigation.

Harvard

Ashkenazi A., Pai R. C., Fong S., Leung S., Lawrence D. A., Marsters S. A., Blackie C., Chang L., McMurtrey A. E., Hebert A., DeForge L., Koumenis I. L., Lewis D., Harris L., Bussiere J., Koeppen H., Shahrokh Z. and Schwall R. H. (19990812). Safety and antitumor activity of recombinant soluble Apo2 ligand. : The Journal of clinical investigation.

MLA

Ashkenazi A, Pai R C, Fong S, Leung S, Lawrence D A, Marsters S A, Blackie C, Chang L, McMurtrey A E, Hebert A, DeForge L, Koumenis I L, Lewis D, Harris L, Bussiere J, Koeppen H, Shahrokh Z and Schwall R H. Safety and antitumor activity of recombinant soluble Apo2 ligand. : The Journal of clinical investigation. 19990812.